Pms-Sodium Polystyrene Sulfonate and Siltuximab Intravenous
Determining the interaction of Pms-Sodium Polystyrene Sulfonate and Siltuximab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: sodium polystyrene sulfonate
Brand name: Kalexate, Kayexalate, Kionex
Synonyms: Sodium polystyrene sulfonate, Sodium Polystyrene Sulfonate
Generic Name: siltuximab
Brand name: Sylvant
Synonyms: Siltuximab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Pms-Sodium Polystyrene Sulfonate-Silvadene
- Pms-Sodium Polystyrene Sulfonate-Silvadene Topical
- Pms-Sodium Polystyrene Sulfonate-SilvaSorb
- Pms-Sodium Polystyrene Sulfonate-Silver
- Pms-Sodium Polystyrene Sulfonate-Silver Nitrate
- Pms-Sodium Polystyrene Sulfonate-Silver Nitrate Applicators
- Siltuximab Intravenous-Pneumococcal 13-valent conjugate vaccine
- Siltuximab Intravenous-Pneumococcal 13-valent vaccine, diphtheria conjugate Intramuscular
- Siltuximab Intravenous-Pneumococcal Conjugate Vaccine (13-Valent)
- Siltuximab Intravenous-Pneumococcal Conjugate Vaccine (7-Valent)
- Siltuximab Intravenous-Pneumococcal Polysaccharide Vaccine (23-Valent)
- Siltuximab Intravenous-Pneumococcal polysaccharides vaccine (PPSV), 23-valent